These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. Seidenfeld J; Samson DJ; Aronson N; Albertson PC; Bayoumi AM; Bennett C; Brown A; Garber A; Gere M; Hasselblad V; Wilt T; Ziegler K Evid Rep Technol Assess (Summ); 1999 May; (4):i-x, 1-246, I1-36, passim. PubMed ID: 11098244 [TBL] [Abstract][Full Text] [Related]
5. Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma. Samson DJ; Seidenfeld J; Schmitt B; Hasselblad V; Albertsen PC; Bennett CL; Wilt TJ; Aronson N Cancer; 2002 Jul; 95(2):361-76. PubMed ID: 12124837 [TBL] [Abstract][Full Text] [Related]
6. Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis. Seidenfeld J; Samson DJ; Hasselblad V; Aronson N; Albertsen PC; Bennett CL; Wilt TJ Ann Intern Med; 2000 Apr; 132(7):566-77. PubMed ID: 10744594 [TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of androgen suppression therapies in advanced prostate cancer. Bayoumi AM; Brown AD; Garber AM J Natl Cancer Inst; 2000 Nov; 92(21):1731-9. PubMed ID: 11058616 [TBL] [Abstract][Full Text] [Related]
8. [First line therapy in the treatment of metastatic prostate cancer]. Sakai H; Kanetake H Gan To Kagaku Ryoho; 2003 Jan; 30(1):43-9. PubMed ID: 12557704 [TBL] [Abstract][Full Text] [Related]
9. Non-steroidal antiandrogen monotherapy compared with luteinizing hormone-releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer: a Cochrane systematic review. Kunath F; Grobe HR; Rücker G; Motschall E; Antes G; Dahm P; Wullich B; Meerpohl JJ BJU Int; 2015 Jul; 116(1):30-6. PubMed ID: 25523493 [TBL] [Abstract][Full Text] [Related]
10. [Keyrole of endocrinology in the victory against prostate cancer]. Labrie F Bull Cancer; 2006 Sep; 93(9):949-58. PubMed ID: 16980238 [TBL] [Abstract][Full Text] [Related]
14. [EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer]. Mottet N; Bellmunt J; Bolla M; Joniau S; Mason M; Matveev V; Schmid HP; van der Kwast T; Wiegel T; Zattoni F; Heidenreich A Actas Urol Esp; 2011; 35(10):565-79. PubMed ID: 21757258 [TBL] [Abstract][Full Text] [Related]
15. Commentary on maximal androgen blockade in prostate cancer: a theory to put into practice? Denis L Prostate; 1995 Nov; 27(5):233-40. PubMed ID: 7479390 [TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
17. Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens. Caubet JF; Tosteson TD; Dong EW; Naylon EM; Whiting GW; Ernstoff MS; Ross SD Urology; 1997 Jan; 49(1):71-8. PubMed ID: 9000189 [TBL] [Abstract][Full Text] [Related]
18. The changing face of hormonal therapy for prostate cancer. Seruga B; Tannock IF Ann Oncol; 2008 Sep; 19 Suppl 7():vii79-85. PubMed ID: 18790984 [No Abstract] [Full Text] [Related]
19. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE). Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR; Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313 [TBL] [Abstract][Full Text] [Related]
20. Patterns of androgen deprivation therapies among men diagnosed with localised prostate cancer: a population-based study. Lycken M; Garmo H; Adolfsson J; Stattin P; Holmberg L; Bill-Axelson A Eur J Cancer; 2014 Jul; 50(10):1789-1798. PubMed ID: 24736041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]